Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00952250 · ClinicalTrials.gov registry record · NA
Targeted Feedback Reports to Improve Acute Coronary Syndromes (ACS) Care
A NA study of Acute Coronary Syndromes, sponsored by Duke University.
- Completed
- Registry status
- NA
- Development phase
- 149
- Enrollment target
- 1
- Study location
NCT00952250 is a NA study of Acute Coronary Syndromes that has completed, run by Duke University. The registered enrollment target is 149 participants, below the 787-participant average among 3 other Acute Coronary Syndromes trials with a reported enrollment target (81% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00952250, a NA study of Acute Coronary Syndromes, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- NA
- Development phase
- 149 participants
- Enrollment target
- 1
- Study location
Study Summary
This project is designed to examine the impact of tailored feedback on site performance. The investigators' objective is to evaluate whether a 'personalized and targeted' feedback, education and performance improvement intervention has a greater impact on adherence to recommended guidelines than standard feedback. The investigators hypothesize that a site-specific report with centrally identified targets for improvement paired with target specific interventions will enable sites to quickly identify and prioritize salient problem areas, have ready access to an analysis of factors that underlie problems, and formulate an effective action plan. The investigators also hypothesize that those hospitals randomized to receive intervention will be more likely to improve their overall performance, as well as their target specific performance, during the period of observation in direct response to activated QI processes. Outcomes: The primary outcome is improvement in the overall composite of all metrics eligible for intervention regardless of their selection as targets. The secondary outcome is improvement in the composite of targeted metrics. Outcomes will be assessed in all participating sites, and in among relevant performance subgroups (low performers, academic centers, full service, and among medication versus process metrics).
Conditions Studied
Interventions
- BEHAVIORAL Targeted Feedback Reports
- BEHAVIORAL Targeted Feedback Report
Study Locations (1)
North Carolina
- Duke University Health System - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 149 participants |
| Start Date | 2009-02 |
| Est. Completion | 2011-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00952250
The ClinicalTrials.gov registry entry for NCT00952250 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 149 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 787-participant average among 3 other Acute Coronary Syndromes trials with a reported enrollment target (81% lower). The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Acute Coronary Syndromes appearing as the primary indexed condition, and to 2 interventions - of which Targeted Feedback Reports is the first listed.
NCT00952250 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT00952250 about?
NCT00952250 is a clinical study titled "Targeted Feedback Reports to Improve Acute Coronary Syndromes (ACS) Care". This project is designed to examine the impact of tailored feedback on site performance. The investigators' objective is to evaluate whether a 'personalized and targeted' feedback, education and performance improvement intervention has a greater impact on adherence to recommended guidelines than st...
What is the current status of trial NCT00952250?
This trial is currently completed. It is a NA study. The enrollment target is 149 participants. The study started on 2009-02. Estimated completion is 2011-07.
What conditions does trial NCT00952250 study?
This clinical trial studies the following conditions: Acute Coronary Syndromes.
What interventions are being tested in trial NCT00952250?
The interventions under investigation include: Targeted Feedback Reports (BEHAVIORAL), Targeted Feedback Report (BEHAVIORAL).
Who is sponsoring clinical trial NCT00952250?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00952250 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Coronary Syndromes
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Study of Women With Acute Coronary Syndromes and Nonobstructive Coronary Artery Disease
ACTIVE NOT RECRUITING · NA
-
Focused Orticumab Research for Treating Inflammation in Coronary Arteries
RECRUITING · Phase 2
-
Investigation of the Biomarker Copeptin in Patients With Acute Myocardial Infarction
COMPLETED
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.